Show simple item record

dc.contributor.authorBitzan, Martin
dc.date.accessioned2024-05-20T08:28:55Z
dc.date.available2024-05-20T08:28:55Z
dc.date.issued2023
dc.identifier.other204-2023.172
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/1449
dc.description.abstractAbstract: The efficacy of the B cell-targeting drug rituximab (RTX) in childhood idiopathic nephrotic syndrome (INS) suggests that B cells may be implicated in disease pathogenesis. However, B cell characterization in children with INS remains limited. Here, using single-cell RNA sequencing, we demonstrate that a B cell transcriptional program poised for effector functions represents the major immune perturbation in blood samples from children with active INS. This transcriptional profile was associated with an extrafollicular B cell response marked by the expansion of atypical B cells (atBCs), marginal zonelike B cells, and antibody-secreting cells (ASCs). Flow cytometry of blood from 13 children with active INS and 24 healthy donors confirmed the presence of an extrafollicular B cell response denoted by the expansion of proliferating RTXsensitive extrafollicular (CXCR5– ) CD21low T-bet+ CD11c+ atBCs and short-lived T-bet+ ASCs in INS. Together, our study provides evidence for an extrafollicular origin for humoral immunity in active INS.en_US
dc.language.isoenen_US
dc.subjectIdiopathic nephrotic syndrome (INS)en_US
dc.subjectChildhooden_US
dc.subjectRituximab (RTX)en_US
dc.titleThe extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndromeen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record